Across the whole pharma sector, there are four or five stocks big one out there which are going to gain market share. So, CDMO is one space within pharma which should do well as we go along. But pharma as a whole space per se has been doing okay and we continue to believe that incrementally also pharma should continue to do well in the coming year also.
Adani Total Gas Q1 Results: Cons PAT down 4% YoY to Rs 165 crore but revenue rises 21%
Adani Total Gas reported a slight dip in Q1 net profit, reaching Rs 165 crore, while revenue surged by 21% to Rs 1,498 crore. Volume